A new study of 192 pharmaceutical advertisements in biomedical journals found that only 18 percent were compliant with Food and Drug Administration guidelines, and over half failed to quantify serious risks including death.
A new study of 192 pharmaceutical advertisements in biomedical journals found that only 18 percent were compliant with Food and Drug Administration guidelines, and over half failed to quantify serious risks including death.